糖尿病患者使用降糖药物与新发心房颤动 - Suppr

Glucose-lowering drug use and new-onset atrial fibrillation in patients with diabetes mellitus.

作者信息

Fauchier Gregoire, Bisson Arnaud, Bodin Alexandre, Herbert Julien, Angoulvant Denis, Ducluzeau Pierre Henri, Lip Gregory Y H, Fauchier Laurent

机构信息

Service de Médecine Interne, Unité d'Endocrinologie Diabétologie et Nutrition, Centre Hospitalier Universitaire et Faculté de Médecine, Université de Tours, Tours, France.

Service de Cardiologie, Centre Hospitalier Universitaire et Faculté de Médecine, Université de Tours, Tours, France.

出版信息

Diabetologia. 2021 Nov;64(11):2602-2605. doi: 10.1007/s00125-021-05551-y. Epub 2021 Aug 25.

DOI:10.1007/s00125-021-05551-y

PMID:34435218

Abstract

摘要

相似文献

Glucose-lowering drug use and new-onset atrial fibrillation in patients with diabetes mellitus.

Diabetologia. 2021 Nov;64(11):2602-2605. doi: 10.1007/s00125-021-05551-y. Epub 2021 Aug 25.

Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute Outcomes.

Sci Rep. 2018 Oct 11;8(1):15142. doi: 10.1038/s41598-018-33483-y.

Cardiovascular safety of glucose-lowering agents as add-on medication to metformin treatment in type 2 diabetes: report from the Swedish National Diabetes Register.

Diabetes Obes Metab. 2016 Oct;18(10):990-8. doi: 10.1111/dom.12704. Epub 2016 Jul 19.

Add-on therapy in metformin-treated patients with type 2 diabetes at moderate cardiovascular risk: a nationwide study.

Cardiovasc Diabetol. 2020 Jul 6;19(1):107. doi: 10.1186/s12933-020-01078-5.

Incretin-based therapy and the risk of diabetic foot ulcers and related events.

Diabetes Obes Metab. 2024 Sep;26(9):3764-3780. doi: 10.1111/dom.15721. Epub 2024 Jul 1.

[Attention to the use of oral anti-diabetic medication in older adults with type 2 diabetes].

Nihon Rinsho. 2013 Nov;71(11):1987-92.

SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management.

Diabetes Care. 2018 Aug;41(8):1543-1556. doi: 10.2337/dc18-0588.

(7) Approaches to glycemic treatment.

Diabetes Care. 2015 Jan;38 Suppl:S41-8. doi: 10.2337/dc15-S010.

Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy.

Lancet. 2015 May 23;385(9982):2107-17. doi: 10.1016/S0140-6736(14)61402-1.

[Management of Type 2 Diabetes: a Practical Approach].

Praxis (Bern 1994). 2016 Jun 8;105(12):699-702. doi: 10.1024/1661-8157/a002368.

引用本文的文献

SGLT2 inhibitor reduces atrial tachyarrhythmia recurrence post-cryoballoon ablation: a prospective observational cohort study in patients with and without diabetes.

BMC Cardiovasc Disord. 2025 Aug 26;25(1):633. doi: 10.1186/s12872-025-05078-9.

Non-Anticoagulation Strategies Aimed at Primary Stroke Prevention in Nascent Atrial Fibrillation.

Biomedicines. 2025 Mar 7;13(3):660. doi: 10.3390/biomedicines13030660.

Mitochondrial Dysfunction in Atrial Fibrillation: The Need for a Strong Pharmacological Approach.

Biomedicines. 2024 Nov 27;12(12):2720. doi: 10.3390/biomedicines12122720.

Effect of different hypoglycemic drugs and insulin on the risk of new-onset atrial fibrillation in people with diabetes: a network meta-analysis.

Eur J Med Res. 2024 Jul 31;29(1):399. doi: 10.1186/s40001-024-01954-w.

Metformin reduces new-onset atrial fibrillation risk rather than atrial fibrillation burden in type 2 diabetes patients: A case-control study.

Heliyon. 2024 May 9;10(10):e30992. doi: 10.1016/j.heliyon.2024.e30992. eCollection 2024 May 30.

Relationship between Glucagon-like Peptide-1 Receptor Agonists and Cardiovascular Disease in Chronic Respiratory Disease and Diabetes.

Biomedicines. 2024 Feb 22;12(3):488. doi: 10.3390/biomedicines12030488.

Accumulated hypertension burden on atrial fibrillation risk in diabetes mellitus: a nationwide population study.

Cardiovasc Diabetol. 2023 Jan 19;22(1):12. doi: 10.1186/s12933-023-01736-4.

A meta-analysis evaluating indirectly GLP-1 receptor agonists and arrhythmias in patients with type 2 diabetes and myocardial infarction.

Front Cardiovasc Med. 2022 Oct 5;9:1019120. doi: 10.3389/fcvm.2022.1019120. eCollection 2022.

Association of Sodium-Glucose Cotransporter-2 Inhibitors With Incident Atrial Fibrillation in Older Adults With Type 2 Diabetes.

JAMA Netw Open. 2022 Oct 3;5(10):e2235995. doi: 10.1001/jamanetworkopen.2022.35995.

Effect of metformin on adverse outcomes in T2DM patients: Systemic review and meta-analysis of observational studies.

Front Cardiovasc Med. 2022 Sep 23;9:944902. doi: 10.3389/fcvm.2022.944902. eCollection 2022.

本文引用的文献

Sex, age, type of diabetes and incidence of atrial fibrillation in patients with diabetes mellitus: a nationwide analysis.

Cardiovasc Diabetol. 2021 Jan 22;20(1):24. doi: 10.1186/s12933-021-01216-7.

SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: a systematic review with meta-analysis of 16 randomized controlled trials.

Cardiovasc Diabetol. 2020 Aug 26;19(1):130. doi: 10.1186/s12933-020-01105-5.

Atrial Fibrillation and Diabetes Mellitus: JACC Review Topic of the Week.

J Am Coll Cardiol. 2019 Aug 27;74(8):1107-1115. doi: 10.1016/j.jacc.2019.07.020.

Risk Factors for Atrial Fibrillation in People With Type 1 Diabetes: An Observational Cohort Study of 36,258 Patients From the Swedish National Diabetes Registry.

Diabetes Care. 2019 Aug;42(8):1530-1538. doi: 10.2337/dc18-2457. Epub 2019 Jun 6.

No evidence of a causal association of type 2 diabetes and glucose metabolism with atrial fibrillation.

Diabetologia. 2019 May;62(5):800-804. doi: 10.1007/s00125-019-4836-y. Epub 2019 Feb 27.

Antihyperglycemic drugs use and new-onset atrial fibrillation: A population-based nested case control study.

PLoS One. 2018 Aug 30;13(8):e0197245. doi: 10.1371/journal.pone.0197245. eCollection 2018.

Dipeptidyl peptidase-4 inhibitor decreases the risk of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in Taiwan.

Cardiovasc Diabetol. 2017 Dec 19;16(1):159. doi: 10.1186/s12933-017-0640-5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Glucose-lowering drug use and new-onset atrial fibrillation in patients with diabetes mellitus.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Glucose-lowering drug use and new-onset atrial fibrillation in patients with diabetes mellitus.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献